Tag: COVID-19

US rates of depression are triple pre-COVID-19 levels

Editor's Note This study led by researchers at the Boston University School of Public Health finds that depression symptoms in the US are three-fold higher than they were before the COVID-19 pandemic. Of 1,441 individuals surveyed during the COVID-19 pandemic and 5,065 surveyed before the pandemic, depression symptoms were higher…

Read More

By: Judy Mathias
September 3, 2020
Share

CDC asks states to be ready to distribute COVID-19 vaccines on Nov 1

Editor's Note In an August 27 letter, Robert Redfield, MD, director of the Centers for Disease Control and Prevention (CDC), asked the nation’s governors to have COVID-19 vaccine distribution sites fully operational by November 1, the September 2 McClatchy DC reports. Delivery firms received guidance to prepare freezer farms in…

Read More

By: Judy Mathias
September 3, 2020
Share

Meta-analysis finds link between corticosteroids, improved mortality in COVID-19 patients

Editor's Note This prospective meta-analysis from the World Health Organization (WHO) Rapid Evidence Appraisal for COVID-19 Therapies, which pooled data from seven randomized clinical trials of critically ill patients with COVID-19, finds that administration of systemic corticosteroids, compared with usual care or placebo, was associated with lower 28-day all-cause mortality.…

Read More

By: Judy Mathias
September 3, 2020
Share

Fauci says COVID-19 vaccine trials could end early if results are overwhelmingly positive

Editor's Note Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health told the Kaiser Health News on September 1 that a COVID-19 vaccine could be available earlier than expected if clinical trial results are overwhelmingly positive. An independent Data and…

Read More

By: Judy Mathias
September 3, 2020
Share

National Academies release COVID-19 vaccine distribution proposal

Editor's Note The National Academies of Sciences, Engineering, and Medicine, on September 1, released draft guidelines to help policymakers plan for equitable allocation of a COVID-19 vaccine. The committee that drafted the guidelines was formed at the request of the National Institutes of Health and Centers for Disease Control and…

Read More

By: Judy Mathias
September 2, 2020
Share

Study: Humoral immune response to COVID-19 in Iceland

Editor's Note This study by researchers from Iceland finds that antibodies against COVID-19 remained stable 4 months after diagnosis. The researchers measured antibodies in serum samples from 30,576 people in Iceland, using six assays (including two pan-immunoglobulin (pan-Ig) assays). They then tested 2,102 samples collected from 1,237 people up to…

Read More

By: Judy Mathias
September 2, 2020
Share

CDC: Prevalence, features of COVID-19 infection in frontline healthcare workers

Editor's Note This study by researchers from the Centers for Disease Control and Prevention (CDC) and 13 academic medical centers in 12 states found that 6% of healthcare workers had antibody evidence of COVID-19 infection, but 29% of them were asymptomatic and 69% had not received a diagnosis of COVID-19.…

Read More

By: Judy Mathias
September 1, 2020
Share

WHO recommends against face masks for children below age 5

Editor's Note The World Health Organization (WHO) on August 21 recommended that children in the community setting under age 5 not wear face masks as a preventive measure against COVID-19. Other recommendations include: For those aged 6 to 11 years, there should be a risk-based approach that considers factors such…

Read More

By: Judy Mathias
September 1, 2020
Share

Study: Who should receive COVID-19 vaccine first?

Editor's Note This study, led by economists from Washington University in St Louis, finds that the ideal COVID-19 vaccine policy should emphasize age more than work-exposure risk for vaccination priority. To provide a best-practice scenario to supplement a vaccine distribution strategy, the researchers tracked eight age groups in more than…

Read More

By: Judy Mathias
August 31, 2020
Share

FDA could fast-track COVID-19 vaccine approval

Editor's Note In an interview with the Financial Times, Food & Drug Administration (FDA) Commissioner Stephen Hahn, MD, on August 30, said the FDA could fast-track approval of a COVID-19 vaccine before late-stage clinical trials are complete if regulators believe the benefits of doing so outweigh the risks. Dr Hahn…

Read More

By: Judy Mathias
August 31, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat